Business
Growing Use of Steriwave Across Surgery Types
Growing Use of Steriwave Across Surgery Types.
About this update from Ondine Biomedical, Inc.
[{"type":"text","content":"\n\n14 July 2025\nONDINE BIOMEDICAL INC.\n(\"Ondine Biomedical\", \"Ondine\" or the \"Company\")\nGrowing Use of Steriwave Across Surgery Types\nOndine Biomedical Inc. (AIM: OBI) reports increasing clinical adoption of its light-activated antimicrobial therapy, Steriwave®, across a broad range of surgical specialities in hospitals throughout the UK and Canada to reduce surgical site infections (SSIs).\nHospitals are now routinely implementing Steriwave nasal decolonisation prior to major surgeries - including cardiac, orthopaedic, neurosurgical, ENT, spinal, and cosmetic procedures - as awareness grows of its effectiveness in reducing SSIs.\nSSIs remain a significant concern in surgical care, contributing to approximately 3% mortality,[1] extended hospital stays averaging nearly 10 additional days.[2] A comprehensive study in Alberta, Canada, found that complex SSIs following hip and knee replacements can cost hospitals up to CA$95,000 per case and pose serious health risks for patients.[3]\nThe patient's nasal passages are a significant source of post-surgical infections, with studies indicating that up to 69% of SSIs originate from pathogens that can colonise the nose.[4][5]-[6] Leading health authorities, including the CDC, WHO, and SHEA, strongly recommend pre-operative nasal decolonisation as an effective strategy to lower the risk of infection. Steriwave offers a cutting-edge, light-activated antimicrobial therapy designed to eliminate these nasal pathogens, thereby enhancing patient safety and surgical outcomes.\nCarolyn Cross, CEO of Ondine, commented:\n\"It's encouraging to see Steriwave gaining recognition across such a wide range of surgical specialties. In contrast to mupirocin - the current standard for nasal decolonisation despite its limited bacterial spectrum and rising resistance - Steriwave offers a fast-acting, resistance-free alternative that is effective across nasal pathogens, including bacteria, viruses and fungi. In some hospitals, mupirocin resistance exceeds 70%, underscoring the urgent need for more versatile and reliable infection prevention tools like Steriwave.\"\nSteriwave is a non-invasive, painless nasal treatment that uses a proprietary photosensitive agent activated by red light to destroy harmful bacteria, viruses, and fungi. The procedure takes five minutes, is effective immediately, and allo...